BRCA1 and cancer: Furthermore, being FHS7 positive was associated with a 3-fold increase in the risk of being BRCA1/2 positive for both sexes and a 44% increase in cancer risk among living female individuals, indicating that FHS7 is useful for indicating genetic risk even without counselor validation.